These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21531972)

  • 1. Bioidentical hormone therapy.
    Files JA; Ko MG; Pruthi S
    Mayo Clin Proc; 2011 Jul; 86(7):673-80, quiz 680. PubMed ID: 21531972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
    Zeng Z; Jiang X; Li X; Wells A; Luo Y; Neapolitan R
    PLoS One; 2018; 13(5):e0197064. PubMed ID: 29768475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of replacement hormonal therapy on the cardiovascular system of postmenopausal women].
    Klimenchenko NI
    Akush Ginekol (Mosk); 1995; (3):10-4. PubMed ID: 7653719
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom experience after discontinuing use of estrogen plus progestin.
    Ockene JK; Barad DH; Cochrane BB; Larson JC; Gass M; Wassertheil-Smoller S; Manson JE; Barnabei VM; Lane DS; Brzyski RG; Rosal MC; Wylie-Rosett J; Hays J
    JAMA; 2005 Jul; 294(2):183-93. PubMed ID: 16014592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(5):359-364. PubMed ID: 28339370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
    L'Hermite M
    Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
    Reuben DB; Palla SL; Hu P; Reboussin BA; Crandall C; Herrington DM; Barrett-Connor E; Greendale GA
    Am J Med; 2006 Feb; 119(2):167.e1-8. PubMed ID: 16443423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review.
    Mirkin S; Amadio JM; Bernick BA; Pickar JH; Archer DF
    Maturitas; 2015 May; 81(1):28-35. PubMed ID: 25835751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestins initiate adverse events of menopausal estrogen therapy.
    Thomas T; Rhodin J; Clark L; Garces A
    Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
    Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B
    Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
    Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G
    Menopause; 2010; 17(3):622-9. PubMed ID: 20215977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-α and -β.
    Perkins MS; Louw-du Toit R; Africander D
    J Steroid Biochem Mol Biol; 2017 Nov; 174():27-39. PubMed ID: 28743541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioidentical hormone therapy in menopause: relevance in dermatology.
    Borda LJ; Wong LL; Tosti A
    Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
    Deleruyelle LJ
    Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.